Design of anticancer drugs using modeling techniques.
Flexibility of intercalation site geometries within a B-DNA helix was investigated in the twist-shift plane using energy minimization methods. The parameters optimized included sugar conformation, the glycosidic angles and phosphodiester torsion angles. Our calculations show several regions of energetically favorable intercalation geometries in the twist-shift plane. Modeling studies using interactive computer graphics and electrostatic potential surface compatibility provided initial hypotheses for the structures of the drug-DNA complexes. These hypotheses were supported and extended by energy minimizations of these complexes. Binding positions, conformational features and relative minimum binding energies of two anticancer drugs, mitoxantrone and bisantrene, were computed for intercalation complexes with DNA in the theoretically defined intercalation sites. Mitoxantrone intercalates DNA from the minor groove and the side chain OH or NH groups are involved in hydrogen bonds with the main chain phosphate groups of DNA, thereby cross-linking the complementary strands. The hydroxyl groups of mitoxantrone can also participate in hydrogen bonding with phosphate oxygens of another chain, thereby cross-linking DNA helices. Bisantrene intercalates DNA favorably from the major groove and the NH group of the dihydroimidazole ring can participate in hydrogen bonding with the phosphate oxygens of the backbone. These models are consistent with the physicochemical and electron microscopic studies of the interaction of mitoxantrone and bisantrene with DNA. Our results are now being used to guide the design of novel anticancer drugs that should interact with DNA in a manner similar to that proposed for our representative drugs.
D000873:Anthracenes / Q000378:metabolism; D000880:Anthraquinones / Q000378:metabolism; D000970:Antineoplastic Agents / Q000138:chemical synthesis*; D001483:Base Sequence; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D003201:Computers; D003461:Crystallography; D004247:DNA / Q000378:metabolism; D007364:Intercalating Agents / Q000494:pharmacology; D008433:Mathematics; D008942:Mitoxantrone; D008958:Models, Molecular; D011487:Protein Conformation; D014961:X-Ray Diffraction
D000873:Anthracenes; D000880:Anthraquinones; D000970:Antineoplastic Agents; D007364:Intercalating Agents; C031404:bisantrene; D004247:DNA; D008942:Mitoxantrone